Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence

Differential effects in neuronal cells and on DNA-protein interactions

Bryan Maloney, Yuan Wen Ge, Ronald C. Petersen, John Hardy, Jack T. Rogers, Jordi Pérez-Tur, Debomoy Lahiri

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Variations in levels of apolipoprotein E (ApoE) have been tied to the risk and progression of Alzheimer's disease (AD). Our group has previously compared and contrasted the promoters of the mouse and human ApoE gene (APOE) promoter sequences and found notable similarities and significant differences that suggest the importance of the APOE promoter's role in the human disease. We examine here three specific single-nucleotide polymorphisms within the human APOE promoter region, specifically at - 491 (A/T), - 427 (T/C), and at - 219 (G/T) upstream from the +1 transcription start site. The - 219 and - 491 polymorphic variations have significant association with instance of AD, and - 491AA has significant risk even when stratified for the APOEε4 allele. We also show significant effects on reporter gene expression in neuronal cell cultures, and, notably, these effects are modified by species origin of the cells. The - 491 and - 219 polymorphisms may have an interactive effect in addition to any independent activity. DNA - protein interactions differ between each polymorphic state. We propose SP1 and GATA as candidates for regulatory control of the - 491 and - 219 polymorphic sites. This work's significance lies in drawing connection among APOE promoter polymorphisms' associations with AD to functional promoter activity differences and specific changes in DNA - protein interactions in cell culture-based as-says. Taken together, these results suggest that APOE expression levels are a risk factor for AD irrespective of APOEε4 allele status.

Original languageEnglish
Pages (from-to)185-201
Number of pages17
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume153
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Single Nucleotide Polymorphism
Alzheimer Disease
DNA
Apolipoproteins E
Proteins
Cell Culture Techniques
Alleles
Transcription Initiation Site
Reporter Genes
Genetic Promoter Regions
Gene Expression
Genes

Keywords

  • Aging
  • Alzheimer's disease
  • Dementia
  • Gene regulation
  • Genetics

ASJC Scopus subject areas

  • Genetics(clinical)
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence : Differential effects in neuronal cells and on DNA-protein interactions. / Maloney, Bryan; Ge, Yuan Wen; Petersen, Ronald C.; Hardy, John; Rogers, Jack T.; Pérez-Tur, Jordi; Lahiri, Debomoy.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, No. 1, 01.2010, p. 185-201.

Research output: Contribution to journalArticle

@article{2aa157d90c9c474396df84b509c70ce9,
title = "Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions",
abstract = "Variations in levels of apolipoprotein E (ApoE) have been tied to the risk and progression of Alzheimer's disease (AD). Our group has previously compared and contrasted the promoters of the mouse and human ApoE gene (APOE) promoter sequences and found notable similarities and significant differences that suggest the importance of the APOE promoter's role in the human disease. We examine here three specific single-nucleotide polymorphisms within the human APOE promoter region, specifically at - 491 (A/T), - 427 (T/C), and at - 219 (G/T) upstream from the +1 transcription start site. The - 219 and - 491 polymorphic variations have significant association with instance of AD, and - 491AA has significant risk even when stratified for the APOEε4 allele. We also show significant effects on reporter gene expression in neuronal cell cultures, and, notably, these effects are modified by species origin of the cells. The - 491 and - 219 polymorphisms may have an interactive effect in addition to any independent activity. DNA - protein interactions differ between each polymorphic state. We propose SP1 and GATA as candidates for regulatory control of the - 491 and - 219 polymorphic sites. This work's significance lies in drawing connection among APOE promoter polymorphisms' associations with AD to functional promoter activity differences and specific changes in DNA - protein interactions in cell culture-based as-says. Taken together, these results suggest that APOE expression levels are a risk factor for AD irrespective of APOEε4 allele status.",
keywords = "Aging, Alzheimer's disease, Dementia, Gene regulation, Genetics",
author = "Bryan Maloney and Ge, {Yuan Wen} and Petersen, {Ronald C.} and John Hardy and Rogers, {Jack T.} and Jordi P{\'e}rez-Tur and Debomoy Lahiri",
year = "2010",
month = "1",
doi = "10.1002/ajmg.b.30973",
language = "English",
volume = "153",
pages = "185--201",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence

T2 - Differential effects in neuronal cells and on DNA-protein interactions

AU - Maloney, Bryan

AU - Ge, Yuan Wen

AU - Petersen, Ronald C.

AU - Hardy, John

AU - Rogers, Jack T.

AU - Pérez-Tur, Jordi

AU - Lahiri, Debomoy

PY - 2010/1

Y1 - 2010/1

N2 - Variations in levels of apolipoprotein E (ApoE) have been tied to the risk and progression of Alzheimer's disease (AD). Our group has previously compared and contrasted the promoters of the mouse and human ApoE gene (APOE) promoter sequences and found notable similarities and significant differences that suggest the importance of the APOE promoter's role in the human disease. We examine here three specific single-nucleotide polymorphisms within the human APOE promoter region, specifically at - 491 (A/T), - 427 (T/C), and at - 219 (G/T) upstream from the +1 transcription start site. The - 219 and - 491 polymorphic variations have significant association with instance of AD, and - 491AA has significant risk even when stratified for the APOEε4 allele. We also show significant effects on reporter gene expression in neuronal cell cultures, and, notably, these effects are modified by species origin of the cells. The - 491 and - 219 polymorphisms may have an interactive effect in addition to any independent activity. DNA - protein interactions differ between each polymorphic state. We propose SP1 and GATA as candidates for regulatory control of the - 491 and - 219 polymorphic sites. This work's significance lies in drawing connection among APOE promoter polymorphisms' associations with AD to functional promoter activity differences and specific changes in DNA - protein interactions in cell culture-based as-says. Taken together, these results suggest that APOE expression levels are a risk factor for AD irrespective of APOEε4 allele status.

AB - Variations in levels of apolipoprotein E (ApoE) have been tied to the risk and progression of Alzheimer's disease (AD). Our group has previously compared and contrasted the promoters of the mouse and human ApoE gene (APOE) promoter sequences and found notable similarities and significant differences that suggest the importance of the APOE promoter's role in the human disease. We examine here three specific single-nucleotide polymorphisms within the human APOE promoter region, specifically at - 491 (A/T), - 427 (T/C), and at - 219 (G/T) upstream from the +1 transcription start site. The - 219 and - 491 polymorphic variations have significant association with instance of AD, and - 491AA has significant risk even when stratified for the APOEε4 allele. We also show significant effects on reporter gene expression in neuronal cell cultures, and, notably, these effects are modified by species origin of the cells. The - 491 and - 219 polymorphisms may have an interactive effect in addition to any independent activity. DNA - protein interactions differ between each polymorphic state. We propose SP1 and GATA as candidates for regulatory control of the - 491 and - 219 polymorphic sites. This work's significance lies in drawing connection among APOE promoter polymorphisms' associations with AD to functional promoter activity differences and specific changes in DNA - protein interactions in cell culture-based as-says. Taken together, these results suggest that APOE expression levels are a risk factor for AD irrespective of APOEε4 allele status.

KW - Aging

KW - Alzheimer's disease

KW - Dementia

KW - Gene regulation

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=73949123343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949123343&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30973

DO - 10.1002/ajmg.b.30973

M3 - Article

VL - 153

SP - 185

EP - 201

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 1

ER -